
Gabapentinoids, namely pregabalin and gabapentin, are increasingly prescribed for neurological, pain-related, and psychiatric conditions. Although initially considered to have low misuse potential, accumulating evidence has linked these medications to misuse, dependence, diversion, and overdose, particularly among individuals with substance use disorders. Evidence from Western countries has expanded, but findings from the Arab world remain fragmented. This narrative review examines patterns of gabapentinoid misuse in the Arab world, including user characteristics, risk factors, community pharmacists’ perspectives, and regulatory responses. Studies from Egypt, Jordan, Saudi Arabia, the United Arab Emirates, Oman, Lebanon, and Sudan document gabapentinoid misuse as a regional public health concern in selected populations. Misuse is most frequently reported among males, individuals with substance use disorders, particularly opioid use disorder, and those with psychiatric comorbidities. Common motivations for gabapentinoid use include self-medication for anxiety, sleep disturbances, and pain; recreational use; and enhancement of the effects of other psychoactive substances. Non-prescription access through community pharmacies, extensive off-label prescribing, and limited surveillance systems are recurring themes. Community pharmacists frequently report suspected misuse and emphasize the need for stronger regulatory oversight, professional training, and monitoring. Although regulatory restrictions have been associated with reduced pregabalin utilization and changes in the use of other medications, individual-level substitution remains unestablished. The predominantly cross-sectional evidence also precludes reliable estimates of regional prevalence and trends over time. Gabapentinoid misuse represents an important but insufficiently characterized public health concern in the Arab world. Addressing existing evidence gaps requires strengthening gabapentinoid monitoring within national electronic prescribing systems, adopting a common minimum regional surveillance dataset, implementing brief pharmacy screening and referral procedures, and expanding regional research, while maintaining access to appropriate treatment.
Abstract Background Stigmatising attitudes toward mental illness among non-psychiatric physicians may create barriers to equitable mental health care. Occupational burnout may be associated with these attitudes; however, this relationship remains insufficiently investigated in general hospital settings. Objective To assess stigmatising attitudes toward mental illness among non-psychiatric physicians and examine their associations with specialty, burnout dimensions, psychiatric history, and previous psychiatric training. Methods This analytical cross-sectional study included 300 non-psychiatric physicians. Data were collected over three months, from July to September 2026. Stigma was measured using the 16-item MICA-4, and burnout was assessed using the 22-item Maslach Burnout Inventory–Human Services Survey (MBI-HSS), both administered in English. Analyses included descriptive statistics, independent-samples t tests, one-way ANOVA with Bonferroni-adjusted comparisons, Pearson correlations, multiple linear regression, and an exploratory interaction model. Results The mean MICA-4 score was 43.11 ± 9.31 (range, 19–70). MICA-4 scores differed by specialty, F(2, 297) = 6.53, p = .002, η² = 0.042. Acute-care physicians scored higher than medical physicians after Bonferroni correction ( p = .002); differences between medical and surgical physicians ( p = .054) and between surgical and acute-care physicians ( p = .831) were not statistically significant. In multivariable analysis, surgical specialty (B = 2.79, p = .010), acute-care specialty (B = 5.32, p < .001), emotional exhaustion (B = 0.26, p < .001), and depersonalisation (B = 0.48, p < .001) were positively associated with MICA-4 scores, whereas previous psychiatric training (B = − 4.39, p < .001), personal psychiatric history (B = − 3.13, p = .016), family psychiatric history (B = − 3.25, p = .007), and personal accomplishment (B = − 0.21, p = .002) were inversely associated. The model explained 41.4% of the variance (adjusted R² = 0.393). The exploratory depersonalisation × training interaction was significant (B = − 0.41, 95% CI − 0.79 to − 0.04, p = .030, ΔR² = 0.009). The depersonalisation slope was significant among physicians without prior psychiatric training (B = 0.61, 95% CI 0.38–0.83, p < .001), but not among those with prior training (B = 0.19, 95% CI − 0.13–0.52, p = .245). Conclusion Stigmatising attitudes were associated with burnout dimensions, specialty, psychiatric history, and previous psychiatric training. The exploratory interaction suggests that the association between depersonalisation and MICA-4 scores differed by previous psychiatric training; however, the cross-sectional findings do not establish causality or a protective effect of training.
Abstract Background Suicidal ideation is a major clinical problem in depressive disorders, while conventional antidepressants have delayed effects. Ketamine and esketamine may provide rapid relief, but their effects on suicidal ideation, durability, suicidal behavior, and safety remain uncertain. Aim To evaluate the efficacy, durability, suicidal-behavior outcomes, acceptability, and safety of ketamine and esketamine for suicidal ideation in adults with depression. Methods PubMed/MEDLINE, Scopus, Web of Science Core Collection, and the Cochrane Library were searched from inception through 23 August 2026. Twelve randomized controlled trials (RCTs), involving 1,127 randomized participants, were included. Ketamine and esketamine were analyzed separately. The primary outcome was suicidal-ideation severity at the earliest post-treatment assessment within 24 h. A 72-hour fallback was used for suicidal-ideation remission when no earlier eligible assessment was available. Random-effects meta-analyses used restricted maximum likelihood (REML), with Hartung–Knapp confidence intervals for analyses including at least three trials and classic Wald-type confidence intervals for two-trial analyses. Results Ketamine was associated with lower suicidal-ideation severity in the primary acute analysis (5 trials; 247 participants; Hedges g = − 0.76, 95% CI − 1.14 to − 0.38; I² = 6%; moderate-certainty evidence). Esketamine showed a smaller and imprecise effect (2 trials; 286 participants; g = − 0.21, 95% CI − 0.44 to 0.02; low-certainty evidence). Evidence for suicidal-ideation remission and suicide attempts was imprecise. The acute effect of ketamine on depressive-symptom severity was uncertain, whereas esketamine reduced Montgomery–Åsberg Depression Rating Scale (MADRS) scores. Dissociation was more frequent with both interventions; dizziness and increased blood pressure were also more frequent with esketamine. These safety findings were limited by sparse data and variation in outcome ascertainment. Conclusion Ketamine showed a short-term reduction in suicidal-ideation severity in a small, methodologically limited RCT evidence base, but the magnitude of the drug-specific effect remains uncertain. Evidence for esketamine, remission, durability, prevention of suicidal behavior, and comparative safety remains limited or imprecise. Larger, better-masked trials using standardized suicidality measures and longer follow-up are needed.
Abstract Background Cancer diagnosis in children and adolescents is associated with significant psychological distress. International evidence indicates a high prevalence of anxiety and depression in this population, but evidence from Saudi Arabia and the Gulf region is limited. This study aimed to determine the prevalence and severity of anxiety and depression among children and adolescents with cancer in Saudi Arabia and to examine associations with demographic and clinical variables. Results A total of 67 children and adolescents (aged 8–18 years) with a confirmed cancer diagnosis at a tertiary oncology centre in Jeddah completed an Arabic translation of the Revised Child Anxiety and Depression Scale-25 (RCADS-25). Using the official RCADS-25 T-score tables (Grades 3–12), 18.2% (95% CI: 10.2–30.3%) scored in the clinical range for anxiety, 26.8% (17.0–39.6%) for depression, and 21.8% (12.9–34.4%) for the total score. In exploratory analyses with false discovery rate correction, steroid use was associated with lower scores on all three outcomes (q ≤ 0.022). Older age was associated with higher depression scores (rho = 0.32, p = 0.009, q = 0.084). Girls scored higher than boys, but this difference did not remain after adjustment for steroid use. Fourteen participants (20.9%, 95% CI: 12.9–32.1%) showed item-specific non-response to the item ''I think about death'' (crossing out, refusing, or leaving only this item blank). Across the other 24 items, 0.75% of responses were blank. Findings were similar in sensitivity analyses. Conclusions About one in five children and adolescents with cancer in this Saudi sample scored in the clinical range for anxiety, and about one in four for depression. Item-specific non-response to the item about death was common and deserves attention in clinical assessment. Larger multi-centre studies with diagnostic interviews and Saudi normative data for the RCADS-25 are needed.
Abstract Objectives This cross-sectional study examined the knowledge and social attitudes of medical students at Ankara University Faculty of Medicine regarding Autism Spectrum Disorder (ASD), and, uniquely, compared them by completion of the Child and Adolescent Mental Health and Diseases internship. Methods The study protocol was developed from September 2023; participant recruitment and data collection took place after institutional ethics approval, between 23 February and 27 May 2024. All 1171 students in terms 4, 5 and 6 were invited; 300 volunteered (25.6%) and completed a sociodemographic questionnaire, the Knowledge about Childhood Autism among Health Workers (KCAHW) questionnaire and the Societal Attitudes Towards Autism (SATA) scale. Group comparisons used the Mann-Whitney U and Kruskal-Wallis tests with effect sizes (r, epsilon-squared) and Dunn’s post-hoc test, and the Spearman correlation. Multivariable linear regression with heteroscedasticity-consistent (HC3) standard errors, entering academic term and both internships simultaneously, tested whether internship completion was independently associated with the outcomes; ordinal logistic regression, nonparametric bootstrapping and a within-term analysis served as sensitivity analyses. Significance was set at 0.05. Results Knowledge scores differed across terms (H(2) = 26.74, p < 0.001, epsilon-squared = 0.089); term 5 and term 6 students scored higher than term 4 students, with no difference between terms 5 and 6 (Dunn, Bonferroni-adjusted p = 1.000). Attitudes did not differ across terms (H(2) = 5.41, p = 0.067). In unadjusted analyses, completion of the Child and Adolescent Mental Health and Diseases internship was associated with higher knowledge (Z = 5.92, p < 0.001, r = 0.34) and, marginally, with more favourable attitudes (Z = -1.96, p = 0.050, r = 0.11); completion of the Mental Health and Diseases internship was associated with higher knowledge (Z = 5.25, p < 0.001, r = 0.30) but not with attitudes ( p = 0.275). With academic term and both internships entered in the same model, each internship remained independently associated with higher knowledge (Child and Adolescent: adjusted beta = + 1.49, 95% CI + 0.35 to + 2.64, p = 0.010; Mental Health: adjusted beta = + 1.50, 95% CI + 0.52 to + 2.48, p = 0.003), whereas neither was associated with attitudes ( p = 0.869 and p = 0.931), indicating that the unadjusted attitude association reflected academic seniority rather than the internship. Knowledge and attitude scores were not correlated (Spearman rho = -0.03, p = 0.614). Scores did not differ by parental education, family psychiatric history or acquaintance with an autistic person. Faculty lectures were the most common information source (224/291, 77.0%), followed by social media (150/291, 51.5%). Only 48 students (16.0%) had received any formal ASD training. Conclusion Completion of structured clinical mental-health rotations was independently associated with greater ASD knowledge after adjustment for academic term, whereas the more favourable attitudes observed among internship completers were accounted for by academic seniority rather than by the internship itself. Because the design is cross-sectional, these are associations and no causal effect of the rotations can be inferred. Knowledge and attitudes were uncorrelated, and only a minority of students had received any formal ASD training. The findings support integrating autism-focused clinical training into medical curricula to build knowledge, while suggesting that improving attitudes may require dedicated, contact-rich interventions beyond existing rotations.